{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T12:19:06Z","timestamp":1779106746319,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,18]]},"DOI":"10.7759\/cureus.109096","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T12:04:22Z","timestamp":1779105862000},"source":"Crossref","is-referenced-by-count":0,"title":["From Susceptible to Resistant: The Emergence of Carbapenemase-Producing Escherichia coli"],"prefix":"10.7759","author":[{"given":"Anish C","family":"Kadam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harsha V","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satish R","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22189922","article-title":"Virulence factors of enteric pathogenic Escherichia coli: a review","volume":"22","author":"Pakbin B","year":"2021","unstructured":"Pakbin B, Br\u00fcck WM, Rossen JW. Virulence factors of enteric pathogenic Escherichia coli: a review. Int J Mol Sci. 2021, 22:10.3390\/ijms22189922","journal-title":"Int J Mol Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.ARBA-0026-2017","article-title":"Antimicrobial resistance in Escherichia coli","volume":"6","author":"Poirel L","year":"2018","unstructured":"Poirel L, Madec JY, Lupo A, et al.. Antimicrobial resistance in Escherichia coli. Microbiol Spectr. 2018, 6:10.1128\/microbiolspec.ARBA-0026-2017","journal-title":"Microbiol Spectr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e20059","article-title":"Biofilm-forming antimicrobial-resistant pathogenic Escherichia coli: A one health challenge in Northeast India","volume":"9","author":"Milton AA","year":"2023","unstructured":"Milton AA, Srinivas K, Lyngdoh V, et al.. Biofilm-forming antimicrobial-resistant pathogenic Escherichia coli: A one health challenge in Northeast India. Heliyon. 2023, 9:e20059. 10.1016\/j.heliyon.2023.e20059","journal-title":"Heliyon"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.9734\/JPRI\/2021\/v33i60B34995","article-title":"Pathogenesis of Escherichia coli: a clinical findings","volume":"33(60B)","author":"Jaybhaye A","year":"2021","unstructured":"Jaybhaye A, Deb M. Pathogenesis of Escherichia coli: a clinical findings. jpri. 2021, 33(60B):3185-3191. 10.9734\/JPRI\/2021\/v33i60B34995","journal-title":"jpri"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.21275\/SR221212114934","article-title":"Detection of carbapenemase producing E Coli by phenotypic method (modified Carba NP test)","volume":"11(12)","author":"Tomar S","year":"2022","unstructured":"Tomar S, Prasad RB, Chauhan S, Vashishta R.. Detection of carbapenemase producing E Coli by phenotypic method (modified Carba NP test). ijsr. 2022, 11(12):582-584. 10.21275\/SR221212114934","journal-title":"ijsr"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.105508","article-title":"Escherichia coli: an overview of main characteristics","author":"Basavaraju M","year":"2022","unstructured":"Basavaraju M, Gunashree BS. Escherichia coli: an overview of main characteristics. Escherichia Coli-Old and New Insights. Erjavec MS (ed): IntechOpen, London, UK; 2022. 11:3-24. 10.5772\/intechopen.105508"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/w12061796","article-title":"Physical factors impacting the survival and occurrence of Escherichia coli in secondary habitats","volume":"12(6)","author":"Petersen F","year":"2020","unstructured":"Petersen F, Hubbart JA. Physical factors impacting the survival and occurrence of Escherichia coli in secondary habitats. water. 2020, 12(6):1796. 10.3390\/w12061796","journal-title":"water"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.102613","article-title":"Molecular epidemiology of Escherichia coli clinical isolates from a tertiary care hospital in Uttarakhand, India: insights into antimicrobial resistance (AMR) burden, virulence profiles, and high-risk lineages","volume":"18","author":"Rohilla R","year":"2026","unstructured":"Rohilla R, Bhatia M, Shamanna V, et al.. Molecular epidemiology of Escherichia coli clinical isolates from a tertiary care hospital in Uttarakhand, India: insights into antimicrobial resistance (AMR) burden, virulence profiles, and high-risk lineages. Cureus. 2026, 18:e102613. 10.7759\/cureus.102613","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray CJ","year":"2022","unstructured":"Murray CJ, Ikuta KS, Sharara F, et al.. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022, 399:629-55. 10.1016\/S0140-6736(21)02724-0","journal-title":"Lancet"},{"key":"ref10","article-title":"The perils of medical tourism: NDM-1-positive Escherichia coli causing febrile neutropenia in a medical tourist","volume":"52(4)","author":"Chan HL","year":"2011","unstructured":"Chan HL, Poon LM, Chan SG, Teo JW. The perils of medical tourism: NDM-1-positive Escherichia coli causing febrile neutropenia in a medical tourist. Singapore Med J. 2011, 52(4):299-302.","journal-title":"Singapore Med J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/frabi.2026.1632790","article-title":"Current status of antimicrobial resistance in Indian healthcare system: combating antimicrobial resistance with precision medicine","volume":"5","author":"Shinde A","year":"2026","unstructured":"Shinde A, Mohan A, Bulusu VM, et al.. Current status of antimicrobial resistance in Indian healthcare system: combating antimicrobial resistance with precision medicine. Front Antibiot. 2026, 5:1632790. 10.3389\/frabi.2026.1632790","journal-title":"Front Antibiot"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3934\/microbiol.2018.3.482","article-title":"An overview of the antimicrobial resistance mechanisms of bacteria","volume":"4","author":"Reygaert WC","year":"2018","unstructured":"Reygaert WC. An overview of the antimicrobial resistance mechanisms of bacteria. AIMS Microbiol. 2018, 4:482-501. 10.3934\/microbiol.2018.3.482","journal-title":"AIMS Microbiol"},{"key":"ref13","article-title":"Essentials of Antimicrobial Stewardship Edition-1","author":"Sastry AS","year":"2023","unstructured":"Sastry AS, Priyadarshi K, R Deepashree. Essentials of Antimicrobial Stewardship Edition-1. Jaypee Brothers Medical Publishers, New Delhi, India; 2023."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101781","article-title":"Antimicrobial resistance and mortality following E.\u00a0coli bacteremia","volume":"56","author":"Daneman N","year":"2023","unstructured":"Daneman N, Fridman D, Johnstone J, et al.. Antimicrobial resistance and mortality following E.\u00a0coli bacteremia. EClinicalMedicine. 2023, 56:101781. 10.1016\/j.eclinm.2022.101781","journal-title":"EClinicalMedicine"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189621","article-title":"Clinical and economic impact of antibiotic resistance in developing countries: A systematic review and meta-analysis","volume":"12","author":"Founou RC","year":"2017","unstructured":"Founou RC, Founou LL, Essack SY. Clinical and economic impact of antibiotic resistance in developing countries: A systematic review and meta-analysis. PLoS One. 2017, 12:e0189621. 10.1371\/journal.pone.0189621","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00553-25","article-title":"Molecular characterization of carbapenem-resistant Enterobacterales (CRE) and in vitro activity of novel beta lactams against CRE isolates from Malaysia","volume":"13","author":"Rashid FA","year":"2025","unstructured":"Rashid FA, Suhaila Che Hussin N, Anuar NF, et al.. Molecular characterization of carbapenem-resistant Enterobacterales (CRE) and in vitro activity of novel beta lactams against CRE isolates from Malaysia. Microbiol Spectr. 2025, 13:e0055325. 10.1128\/spectrum.00553-25","journal-title":"Microbiol Spectr"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-024-00996-1","article-title":"Opportunities to enhance diagnostic testing and antimicrobial stewardship: a qualitative multinational survey of healthcare professionals","volume":"13","author":"Jinks T","year":"2024","unstructured":"Jinks T, Subramaniam S, Bassetti M, et al.. Opportunities to enhance diagnostic testing and antimicrobial stewardship: a qualitative multinational survey of healthcare professionals. Infect Dis Ther. 2024, 13:1621-37. 10.1007\/s40121-024-00996-1","journal-title":"Infect Dis Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2021.10.007","article-title":"India's National Action Plan on Antimicrobial Resistance: a critical perspective","volume":"27","author":"Nair M","year":"2021","unstructured":"Nair M, Zeegers MP, Varghese GM, Burza S. India's National Action Plan on Antimicrobial Resistance: a critical perspective. J Glob Antimicrob Resist. 2021, 27:236-8. 10.1016\/j.jgar.2021.10.007","journal-title":"J Glob Antimicrob Resist"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_275_19","article-title":"India's National Action Plan for antimicrobial resistance-an overview of the context, status, and way ahead","volume":"8","author":"Ranjalkar J","year":"2019","unstructured":"Ranjalkar J, Chandy SJ. India's National Action Plan for antimicrobial resistance-an overview of the context, status, and way ahead. J Family Med Prim Care. 2019, 8:1828-34. 10.4103\/jfmpc.jfmpc_275_19","journal-title":"J Family Med Prim Care"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/bacteria3030012","article-title":"Antimicrobial resistance and novel alternative approaches to conventional antibiotics","volume":"3(3)","author":"Berger I","year":"2024","unstructured":"Berger I, Loewy ZG. Antimicrobial resistance and novel alternative approaches to conventional antibiotics. Bacteria. 2024, 3(3):171-182. 10.3390\/bacteria3030012","journal-title":"Bacteria"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/490025-from-susceptible-to-resistant-the-emergence-of-carbapenemase-producing-escherichia-coli","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T12:04:22Z","timestamp":1779105862000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/490025-from-susceptible-to-resistant-the-emergence-of-carbapenemase-producing-escherichia-coli"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.109096","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,18]]}}}